Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus

Jeffrey K. Holden, Soosung Kang, Federico C. Beasley, Maris A. Cinelli, Huiying Li, Saurabh G. Roy, Dillon Dejam, Aimee L. Edinger, Victor Nizet, Richard B. Silverman, Thomas L. Poulos

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Summary Bacterial infections associated with methicillin-resistant Staphylococcus aureus (MRSA) are a major economic burden to hospitals, and confer high rates of morbidity and mortality among those infected. Exploitation of novel therapeutic targets is thus necessary to combat this dangerous pathogen. Here, we report on the identification and characterization, including crystal structures, of two nitric oxide synthase (NOS) inhibitors that function as antimicrobials against MRSA. These data provide the first evidence that bacterial NOS (bNOS) inhibitors can work synergistically with oxidative stress to enhance MRSA killing. Crystal structures show that each inhibitor contacts an active site Ile residue in bNOS that is Val in the mammalian NOS isoforms. Mutagenesis studies show that the additional nonpolar contacts provided by the Ile in bNOS contribute to tighter binding toward the bacterial enzyme.

Original languageEnglish
Pages (from-to)785-792
Number of pages8
JournalChemistry and Biology
Issue number6
StatePublished - 20 Jun 2015

Bibliographical note

Publisher Copyright:
© 2015 Elsevier Ltd All rights reserved.


Dive into the research topics of 'Nitric Oxide Synthase as a Target for Methicillin-Resistant Staphylococcus aureus'. Together they form a unique fingerprint.

Cite this